Patients with Spondyloarthritis and obesity who fail TNF antagonist therapy: Change the subcutaneous injection site before the biologic? Comment on: "Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis" by Shan et al. Joint Bone Spine, 2019, 86, 173-183.

Joint Bone Spine

Rheumatology and Orthopedic department, Princess Grace Hospital, boulevard Pasteur, 98000 Monaco.

Published: January 2020

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jbspin.2019.09.003	DOI Listing

Publication Analysis

patients spondyloarthritis

spondyloarthritis obesity

obesity fail

fail tnf

tnf antagonist

antagonist therapy

therapy change

change subcutaneous

subcutaneous injection

injection site

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!